Cantargia
Nedjad Losic holds an M.Sc. in Mathematics and a diploma in Management of medical product innovation (SIMI). He has more than 25 years experience of providing biostatistics expertise in clinical drug development, mostly in antibody development and oncology. He has been directly involved in the planning and obtaining market approvals for several biological drugs when at Genmab and Y-mAbs. He has held managerial positions for Ferring, Spadille and Genmab and most recently, as Senior Project Biostatistician in Y-mAbs.
This person is not in any offices
Cantargia
1 followers
Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.